Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer
Clinical trial NCT03349710 · COMPLETED
Trial details
- NCT number
- NCT03349710
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-15
- Primary completion
- 2019-10-14
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.